Origin Sciences develops and manufactures innovative diagnostic tools and assays that enable the detection, diagnosis and monitoring of gastrointestinal diseases. The Oricol™ sample collection device is Origin’s flagship product to enter the in vitro diagnostic market, which enables convenient and effective clinical sampling of mucocellular material from the rectum. Using the Oricol™ technology, Origin Sciences is developing a portfolio of assays and seeking collaborations to develop high-value tests for the GI market. Currently in development are tests for colorectal cancer (CRC) and Inflammatory Bowel Disease (IBD). Origin Sciences’ products are developed and manufactured within quality systems accredited to ISO 13485. Founded in 2004, Origin Sciences is based in the UK, with a laboratory in Cambridge and offices in London. Origin Sciences aims to be at the forefront of scientific breakthroughs in the investigation of gastrointestinal diseases.
Looking for a particular Origin Sciences employee's phone or email?
Origin Sciences Questions
The Origin Sciences annual revenue was $400000 in 2026.
Jamie Yexley is the COO of Origin Sciences.
25 people are employed at Origin Sciences.
The NAICS codes for Origin Sciences are [541, 5417, 541714, 54171, 54].
The SIC codes for Origin Sciences are [87, 873].
Top Origin Sciences Employees
-
Andrew Page
Chief Technology Officer at Origin Sciences
Saffron Walden, GB2 -
Hugo Lywood
Managing Director at Origin Sciences
England, United Kingdom1 -
Lee Davy-Martin
Non Executive Director at Origin Sciences
Berkhamsted, GB24 -
Daniel Wise
Chief Scientific Officer at Origin Sciences
Cambridge, GB1 -
Clare Knight
Head of Clinical Operations at Origin Sciences
Downham Market, GB21 -
Barry Skeet
Business Director at Origin Sciences
Portsmouth, GB35+ -
2
